The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats-Reference-Cited by-同舟云学术

The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats

Published:2014-02-12 Issue:2 Volume:35 Page:326-334
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Rodríguez Sarai¹,Raurell Imma¹,Ezkurdia Nahia¹,Augustin Salvador¹,Esteban Rafael¹²,Genescà Joan¹²,Martell María¹

Affiliation:

1. Liver Diseases Laboratory; Liver Unit; Department of Internal Medicine; Hospital Universitari Vall d'Hebron; Institut de Recerca (VHIR); Universitat Autònoma de Barcelona; Barcelona Spain

2. Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd); Madrid Spain

Funder

Agència de Gestió d'Ajuts Universitaris i de Recerca

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12472/fullpdf

Reference30 articles.

1. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis;Schrier;Hepatology,1988

2. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule;Iwakiri;Hepatology,2006

3. The management of portal hypertension: rational basis, available treatments and future options;Bosch;J Hepatol,2008

4. Renal failure in cirrhosis;Gines;N Engl J Med,2009

5. Physiopathology of splanchnic vasodilation in portal hypertension;Martell;World J Hepatol,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Analysis of Dysfunctional Liver Sinusoidal Endothelial Cells Reveals Substantial Differences in Most Common Experimental Models of Chronic Liver Diseases;International Journal of Molecular Sciences;2023-07-25

2. Droxidopa in the Management of Hepatorenal Syndrome;Journal of Pharmacy Practice;2022-04-15

3. Investigation into imbalance of Th1/Th2 cells in cirrhotic, hypersplenic rats;Journal of International Medical Research;2019-12-18

4. A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats;Scientific Reports;2017-01-13